The diversity principle-the intuitive notion that diverse evidence is, all else equal, more persuasive, suggestive, confirmatory, or otherwise better than less varied sets of evidence-is a clear component of scientific practice and endorsed by scientists and philosophers alike. A great body of psychological research on people's understanding and application of the diversity principle exists, yet it remains divided into multiple, distinct research communities, which often come to conflicting conclusions. One reason for this is that the range of tasks and domains investigated is appropriately wide. Without a common understanding of what it means for evidence to be diverse, however, it is hard to compare what are at times diverging results. To address this, I review three perspectives from philosophy on what makes diverse evidence valuable. I will use the perspectives to frame results from psychology and assess whether people understand the value of diverse evidence on both an intuitive and explicit level. My conclusions have a leveled optimism: While people are generally aware of the value of diverse evidence, they often struggle to apply what they know. I argue this is because people do not assess the diversity of their evidence as a matter of course but rely on its intuitive diversity as a cue to its evidential diversity. When this cue is absent, people can overlook otherwise obvious problems with their evidence. This has potential consequences for how people seek out, evaluate, and understand evidence from a variety of domains, but leaves open the possibility that various interventions-such as education or reminders to attend to the quality of evidence-may increase people's application of what they know.'
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3758/s13423-022-02065-5 | DOI Listing |
Endocr Metab Immune Disord Drug Targets
January 2025
Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Lovely Professional University, Panjab, 144001, India.
Diabetes Mellitus (DM) is a complex metabolic disorder characterized by chronic hyperglycemia and poses significant global health challenges. Conventional treatments, such as insulin therapy and lifestyle modifications, have shown limited efficacy in addressing the multifactorial nature of DM. Emerging evidence suggests that gut microbiota, a diverse community of microorganisms critical for metabolism and immune function, plays a pivotal role in metabolic health.
View Article and Find Full Text PDFEndocr Metab Immune Disord Drug Targets
January 2025
Department of Biochemistry, KVG Medical College and Hospital, Sullia 574327, India.
Type 2 Diabetes Mellitus (T2DM) is an etiologically diverse metabolic dysfunction that, if untreated, leads to chronic hyperglycemia. Understanding the etiology of T2DM is critical, as it represents one of the most formidable medical challenges of the twenty-first century. Traditionally, insulin resistance has been recognized as the primary risk factor and a well-known consequence of type 2 diabetes.
View Article and Find Full Text PDFCureus
December 2024
Critical Care Medicine, Star Care Multispeciality Hospital, Kozhikode, IND.
Background: Fluid management is a crucial critical care component, influencing outcomes such as organ function, renal integrity, and survival in critically ill patients. Recent evidence suggests that balanced crystalloids may offer advantages over isotonic saline, particularly in reducing the risk of acute kidney injury (AKI) and other complications. This study aimed to evaluate the impact of balanced crystalloids versus isotonic saline on clinical outcomes in the intensive care unit (ICU), focusing on AKI, renal replacement therapy (RRT), and mortality.
View Article and Find Full Text PDFArbuscular mycorrhizal fungi (AMF, phylum Glomeromycota) are essential to plant community diversity and ecosystem functioning. However, increasing human land use represents a major threat to native AMF globally. Characterizing the loss of AMF diversity remains challenging because many taxa are undescribed, resulting in poor documentation of their biogeography and family-level disturbance sensitivity.
View Article and Find Full Text PDFBrain Behav Immun Health
February 2025
General Direction, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, Rome, 00144, Rome, Italy.
Background: This article analyzes the main coordination needs linked to the diagnosis and treatment of oncological diseases, presenting the various integration tools that our healthcare organization adopted to guarantee continuity of care at the IRCCS IFO (Istituto di Ricovero e Cura a Carattere Scientifico Istituti Fisioterapici Ospitalieri) in Rome. The object of investigation is the disease management team (DMT) organization for the diagnosis and treatment of people suffering from oncological disease and the consequences in terms of improving their management.
Methods: The study focuses, in particular, on the analysis of the different organizational methods chosen for the management of activities related to diagnosis and treatment paths.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!